| Meadowbrook At Oconto Falls | |
| 100 E Highland Dr, Oconto Falls, Wisconsin 54154 | |
| (920) 848-3272 | |
| Name | Meadowbrook At Oconto Falls |
|---|---|
| Location | 100 E Highland Dr, Oconto Falls, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 99 |
| Occupancy Rate | 37.17% |
| Medicare ID (CCN) | 525449 |
| Legal Business Name | Oconto Falls Nursing And Rehab Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1164888525 |
| Organization Name | 100 E. HIGHLAND DRIVE OPERATING COMPANY, LLC |
| Doing Business As | ATRIUM POST ACUTE CARE OF OCONTO FALLS |
| Address | 100 E Highland Dr, Oconto Falls, WI 54154 |
| Phone Number | 920-848-3272 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Holiday drivers leaving home often put themselves in the same dangerous situations as shiftwork and contract commuters returning home.
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
› Verified 5 days ago
| NPI Number | 1306831052 |
| Organization Name | HEYDE HEALTH SYSTEM OCONTO FALLS LLC |
| Doing Business As | SHARPE CARE |
| Address | 100 E Highland Dr, Oconto Falls, WI 54154 |
| Phone Number | 920-848-3272 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Holiday drivers leaving home often put themselves in the same dangerous situations as shiftwork and contract commuters returning home.
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
› Verified 5 days ago
| NPI Number | 1609426337 |
| Organization Name | OCONTO FALLS NURSING AND REHAB LLC |
| Doing Business As | MEADOWBROOK AT OCONTO FALLS |
| Address | 100 E Highland Dr, Oconto Falls, WI 54154 |
| Phone Number | 920-848-3272 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Holiday drivers leaving home often put themselves in the same dangerous situations as shiftwork and contract commuters returning home.
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
› Verified 5 days ago
| NPI Number | 1629496039 |
| Organization Name | PSCN, LLC |
| Doing Business As | SHARPE CARE NURSING & REHABILITATION |
| Address | 100 E Highland Dr, Oconto Falls, WI 54154 |
| Phone Number | 920-848-3272 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Holiday drivers leaving home often put themselves in the same dangerous situations as shiftwork and contract commuters returning home.
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
› Verified 5 days ago
| NPI Number | 1689978215 |
| Organization Name | SHARPE CARE NURSING & REHABILITATION CENTER LLC |
| Address | 100 E Highland Dr, Oconto Falls, WI 54154 |
| Phone Number | 920-848-3272 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Holiday drivers leaving home often put themselves in the same dangerous situations as shiftwork and contract commuters returning home.
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Holiday drivers leaving home often put themselves in the same dangerous situations as shiftwork and contract commuters returning home.
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.47 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 15.04 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 25.53 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.81 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.31 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.48 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.76 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.34 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.79 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.46 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.45 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.66 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Holiday drivers leaving home often put themselves in the same dangerous situations as shiftwork and contract commuters returning home.
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
The risk of dying from injuries is increasing for Americans ages 65 and older according to a new report from the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
› Verified 5 days ago
Meadowbrook At Oconto Falls Location: 100 E Highland Dr, Oconto Falls, Wisconsin 54154 Phone: (920) 848-3272 |